InnoCare Pharma Limited
InnoCare Pharma Limited (INCPF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INCPF · as of Jun 9, 2026
Key Statistics
Explore InnoCare Pharma Limited Data
incpf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
incpf competitorsINCPF
AKBLF
CAMRF
CLCGY
CSMYF
FLMNYStock Performance
Full HistoryAbout InnoCare Pharma Limited
InnoCare Pharma Limited is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments, primarily targeting cancer and autoimmune disorders. A k…
what is innocare pharma limited · incpf stock overview · innocare pharma limited company profile · who is innocare pharma limited ceo · incpf OTC · innocare pharma limited headquarters · innocare pharma limited business segments
About Stock Overview & Key Data
InnoCare Pharma Limited (INCPF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 9, 2021. As of the latest trading session, INCPF stock price is $2.05, with a market capitalization of $3.1B. The stock has returned -37.12% over the past 12 months and +0.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for InnoCare Pharma Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, InnoCare Pharma Limited reported revenue of $2.3B and net income of $625.9M. For detailed data — including InnoCare Pharma Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, InnoCare Pharma Limited (INCPF) stock price is $2.05. The stock is traded on OTC under the ticker symbol INCPF. The 52-week range is $1.55 – $3.26.